Julia Thiel

6PUBLICATIONS
33CO-AUTHORS
BiomaterialsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 11, 2026
The FAP × CD3 bispecific antibody OMTX305 induces T cell-mediated antitumor effects in patient-derived ex vivo models of solid tumors.

|Mar 18, 2026
KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival.

Thomas L Ekstrom, Zhangshuai Dai, Julia Thiel

|Mar 18, 2026
Epigenetic context defines the transcriptional activity of canonical and noncanonical NF-κB signaling in pancreatic cancer.

Joana E Aggrey-Fynn, Joshua Busch, Dominik Saul

|Jan 31, 2026
BCL-xL as a therapeutic target in cetuximab-refractory colorectal cancer.

Stella Asmanidou, Julia Thiel, Thomas L Ekstrom

|Dec 11, 2025
Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse Models.

Dina Mönch, Julia Thiel, Meng Dong

|Jul 09, 2025
Therapeutic targeting of FOSL1 and RELA-dependent transcriptional mechanisms to suppress pancreatic cancer metastasis.

Joana E Aggrey-Fynn, Meghana Manjunath, Ashish Rajput

Pageof 1

Frequent Collaborators

6 joint publications

Meng Dong

3 joint publications

Amro M Abdelrahman

3 joint publications

Steven A Johnsen

2 joint publications

Nadine Schacherer